Kowarski syndrome is characterized by bioinactive growth hormone caused by GH1 mutations. Supplementation is effective in these patients.
1. |
Takahashi Y et al. (1996) Brief report: short stature caused by a mutant growth hormone. |
2. |
Besson A et al. (2005) Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). |
3. |
Takahashi Y et al. (1997) Biologically inactive growth hormone caused by an amino acid substitution. |
4. |
Kowarski AA et al. (1978) Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. |
5. |
Valenta LJ et al. (1985) Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. |
6. |
Bright GM et al. (1983) Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone. |
7. |
Orphanet article Orphanet ID 629 |
8. |
OMIM.ORG article Omim 262650 |
9. |
Wikipedia article Wikipedia EN (Kowarski_syndrome) |